Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

NEWS

Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the competing long-acting injectable (LAI), variability in the timing of funding among certain Criminal Justice System (CJS) accounts and incremental lower trade stocking.
Preliminary Q3 2024 SUBLOCADE NR: $187m to $192m
Revised FY 2024 SUBLOCADE NR: $725m to $745m (+17% at the midpoint vs. FY 2023)
Expected peak SUBLOCADE NR of >$1.5 billion is unchanged, however the Group no longer expects a SUBLOCADE NR run rate of $1 billion exiting 2025.
The Group is actively seeking efficiencies to fuel SUBLOCADE growth and support margins.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
6336 Views
Comment
Sign in to post a comment